Bio Spec

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Overview

Bio Spec Overview

Ignite Creation Date: 2025-12-25 @ 3:19 AM
Last Modification Date: 2025-12-25 @ 3:19 AM
Retention: SAMPLES_WITH_DNA
Description: The study aims to take four blood samples from study participants at time of consent if this is done in person and also at time of CTCA in the intervention arm for long-term storage. The sample types and volumes are detailed below:

* Plasma Li-Hep (approx. 4.7ml)
* Serum Gel (approx. 9ml)
* EDTA (approx. 4.9ml)
* EDTA (approx. 9ml) Where possible, surplus serum and/or plasma will also be obtained from the clinical blood samples sent by the clinical care team during the initial hospital attendance.

All samples will be centrifuged and stored at -80 degrees Celsius.
Section: The study aims to take four blood samples from study participants at time of consent if this is done in person and also at time of CTCA in the intervention arm for long-term storage. The sample types and volumes are detailed below: * Plasma Li-Hep (approx. 4.7ml) * Serum Gel (approx. 9ml) * EDTA (approx. 4.9ml) * EDTA (approx. 9ml) Where possible, surplus serum and/or plasma will also be obtained from the clinical blood samples sent by the clinical care team during the initial hospital attendance. All samples will be centrifuged and stored at -80 degrees Celsius.